6-36676733-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001291549.3(CDKN1A):c.-142+163A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 151,930 control chromosomes in the GnomAD database, including 4,471 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 4471 hom., cov: 32)
Consequence
CDKN1A
NM_001291549.3 intron
NM_001291549.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.392
Publications
5 publications found
Genes affected
CDKN1A (HGNC:1784): (cyclin dependent kinase inhibitor 1A) This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.407 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDKN1A | NM_001291549.3 | c.-142+163A>G | intron_variant | Intron 1 of 3 | NP_001278478.1 | |||
| CDKN1A | NM_001374509.1 | c.-50+163A>G | intron_variant | Intron 1 of 3 | NP_001361438.1 | |||
| CDKN1A | NM_001374510.1 | c.34+163A>G | intron_variant | Intron 1 of 2 | NP_001361439.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CDKN1A | ENST00000448526.6 | c.-38+209A>G | intron_variant | Intron 1 of 3 | 3 | ENSP00000409259.3 | ||||
| CDKN1A | ENST00000615513.4 | c.-6+209A>G | intron_variant | Intron 1 of 2 | 2 | ENSP00000482768.1 | ||||
| CDKN1A | ENST00000459970.1 | n.43+163A>G | intron_variant | Intron 1 of 2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.218 AC: 33127AN: 151814Hom.: 4456 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
33127
AN:
151814
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.218 AC: 33186AN: 151930Hom.: 4471 Cov.: 32 AF XY: 0.219 AC XY: 16266AN XY: 74234 show subpopulations
GnomAD4 genome
AF:
AC:
33186
AN:
151930
Hom.:
Cov.:
32
AF XY:
AC XY:
16266
AN XY:
74234
show subpopulations
African (AFR)
AF:
AC:
13654
AN:
41386
American (AMR)
AF:
AC:
4925
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
332
AN:
3472
East Asian (EAS)
AF:
AC:
2179
AN:
5164
South Asian (SAS)
AF:
AC:
588
AN:
4818
European-Finnish (FIN)
AF:
AC:
1252
AN:
10526
Middle Eastern (MID)
AF:
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9621
AN:
67978
Other (OTH)
AF:
AC:
459
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1213
2426
3640
4853
6066
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
322
644
966
1288
1610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
873
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.